Numab Therapeutics in a CHF 100 Million series C round led by Novo Holdings

Biotech Health services

Investments

20 May 2021

Numab Therapeutics (company)

Biotech Health services

Total investments received (USD): 166.5m

Round value (USD): 111.5m

Round investors: BlackRock Cormorant Asset Management Forbion Capital Partners HBM Healthcare Investments Novo A/S

Industry: Biotech Health services

Biotech Competitive Intelligence Health services Software Services

Investments 19 October 2021

Biotech Health services Pharma

Investments 04 June 2021